inhalatory formulations as solutions or dry powders, for the removal of mucous secretions of the respiratory system
2012
inhalatory formulations in the form of hypertonic solutions or free dry powders preservatives or excipients containing an osmolarity agent selected from NaCl or mannitol and hyaluronic acid MW 300.000 describes - 350,000 obtained by fermentation of the bacterial strain Streptococcus equi zooepidemicus subspecies no haemolytic.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI